MX371037B - Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas. - Google Patents
Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas.Info
- Publication number
- MX371037B MX371037B MX2015016320A MX2015016320A MX371037B MX 371037 B MX371037 B MX 371037B MX 2015016320 A MX2015016320 A MX 2015016320A MX 2015016320 A MX2015016320 A MX 2015016320A MX 371037 B MX371037 B MX 371037B
- Authority
- MX
- Mexico
- Prior art keywords
- oxazolidinone
- prophylaxis
- bacterial diseases
- parenteral treatment
- quinolone hybrid
- Prior art date
Links
- HGKANZZLRDQFIM-UHFFFAOYSA-N 1,3-oxazolidin-2-one;1h-quinolin-2-one Chemical compound O=C1NCCO1.C1=CC=C2NC(=O)C=CC2=C1 HGKANZZLRDQFIM-UHFFFAOYSA-N 0.000 title abstract 3
- 208000035143 Bacterial infection Diseases 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- 229940088710 antibiotic agent Drugs 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dermatology (AREA)
Abstract
La presente invención se refiere al uso de híbridos de oxazolidinona-quinolona para el tratamiento parenteral (especialmente intravenoso) o profilaxis de enfermedades bacterianas. La presente invención se refiere por otra parte a métodos mejorados para administrar antibacterianos de híbridos de oxazolidinona-quinolona.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13002762 | 2013-05-28 | ||
| EP13005745 | 2013-12-10 | ||
| EP13005748 | 2013-12-10 | ||
| PCT/EP2014/001253 WO2014191075A1 (en) | 2013-05-28 | 2014-05-09 | Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or prophylaxis of bacterial diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015016320A MX2015016320A (es) | 2016-06-02 |
| MX371037B true MX371037B (es) | 2020-01-14 |
Family
ID=50721743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015016320A MX371037B (es) | 2013-05-28 | 2014-05-09 | Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas. |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US10723746B2 (es) |
| EP (2) | EP3517106A1 (es) |
| JP (1) | JP6407982B2 (es) |
| KR (1) | KR102214843B1 (es) |
| CN (2) | CN105338972A (es) |
| AU (1) | AU2014273510B2 (es) |
| BR (1) | BR112015029488A8 (es) |
| CA (1) | CA2912590C (es) |
| CY (1) | CY1121996T1 (es) |
| DK (1) | DK3003289T3 (es) |
| ES (1) | ES2726828T3 (es) |
| HK (1) | HK1223306A1 (es) |
| HR (1) | HRP20190977T1 (es) |
| HU (1) | HUE043786T2 (es) |
| IL (1) | IL242771B (es) |
| LT (1) | LT3003289T (es) |
| MX (1) | MX371037B (es) |
| NZ (1) | NZ713945A (es) |
| PL (1) | PL3003289T3 (es) |
| PT (1) | PT3003289T (es) |
| RS (1) | RS58915B1 (es) |
| RU (1) | RU2702364C2 (es) |
| SI (1) | SI3003289T1 (es) |
| WO (1) | WO2014191075A1 (es) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE319710T1 (de) | 2000-12-21 | 2006-03-15 | Pharmacia & Upjohn Co Llc | Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen |
| ES2186550B2 (es) | 2001-06-27 | 2003-11-16 | Vita Lab | Nuevos derivados de oxazolidinonas como antibacterianos. |
| WO2003031441A1 (en) | 2001-10-04 | 2003-04-17 | Morphochen Aktiengesellschaft Für Kombinatorische Chemie | Multiple action compounds |
| WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| ZA200509147B (en) * | 2003-04-30 | 2007-03-28 | Morphochem Ag | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| ES2308171T3 (es) | 2003-04-30 | 2008-12-01 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones. |
| DE10340485B4 (de) | 2003-09-03 | 2015-05-13 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden |
| US8158797B2 (en) * | 2003-12-18 | 2012-04-17 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| PL1709044T5 (pl) * | 2003-12-18 | 2014-03-31 | Morphochem Aktiengesellschaft Fuer Komb Chemie | Antybiotyki hybrydowe oksazolidynon-chinolon |
| AR054608A1 (es) | 2005-08-08 | 2007-06-27 | Actelion Pharmaceuticals Ltd | Derivados de oxazolidinona enlazados a quinolonas como antibacterianos |
| WO2007097940A2 (en) * | 2006-02-13 | 2007-08-30 | Trustees Of Boston University | Reca inhibitors with antibiotic activity, compositions and methods of use |
| TWI374138B (en) | 2006-11-10 | 2012-10-11 | Actelion Pharmaceuticals Ltd | 5-hydroxymethyl-oxazolidin-2-one derivatives |
| CL2007003332A1 (es) | 2006-11-24 | 2008-06-20 | Actelion Pharmaceuticals Ltd | Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas. |
| BRPI0911991B8 (pt) * | 2008-05-09 | 2021-05-25 | Actelion Pharmaceuticals Ltd | derivados de 5-hidroximetil-oxazolidin-2-ona para o tratamento de doenças intestinais bacterianas |
-
2014
- 2014-05-09 RU RU2015155645A patent/RU2702364C2/ru active
- 2014-05-09 US US14/894,400 patent/US10723746B2/en active Active
- 2014-05-09 PT PT14723716T patent/PT3003289T/pt unknown
- 2014-05-09 CN CN201480031373.3A patent/CN105338972A/zh active Pending
- 2014-05-09 CA CA2912590A patent/CA2912590C/en active Active
- 2014-05-09 AU AU2014273510A patent/AU2014273510B2/en active Active
- 2014-05-09 JP JP2016518855A patent/JP6407982B2/ja active Active
- 2014-05-09 ES ES14723716T patent/ES2726828T3/es active Active
- 2014-05-09 EP EP19157832.7A patent/EP3517106A1/en not_active Withdrawn
- 2014-05-09 LT LTEP14723716.8T patent/LT3003289T/lt unknown
- 2014-05-09 EP EP14723716.8A patent/EP3003289B1/en active Active
- 2014-05-09 PL PL14723716T patent/PL3003289T3/pl unknown
- 2014-05-09 DK DK14723716.8T patent/DK3003289T3/da active
- 2014-05-09 MX MX2015016320A patent/MX371037B/es active IP Right Grant
- 2014-05-09 KR KR1020157036752A patent/KR102214843B1/ko active IP Right Grant
- 2014-05-09 HU HUE14723716A patent/HUE043786T2/hu unknown
- 2014-05-09 CN CN202011016666.8A patent/CN112089714A/zh active Pending
- 2014-05-09 SI SI201431204T patent/SI3003289T1/sl unknown
- 2014-05-09 RS RS20190554A patent/RS58915B1/sr unknown
- 2014-05-09 WO PCT/EP2014/001253 patent/WO2014191075A1/en active Application Filing
- 2014-05-09 NZ NZ713945A patent/NZ713945A/en unknown
- 2014-05-09 BR BR112015029488A patent/BR112015029488A8/pt not_active Application Discontinuation
-
2015
- 2015-11-25 IL IL242771A patent/IL242771B/en active IP Right Grant
-
2016
- 2016-10-11 HK HK16111733.1A patent/HK1223306A1/zh unknown
-
2019
- 2019-05-20 CY CY20191100532T patent/CY1121996T1/el unknown
- 2019-05-29 HR HRP20190977TT patent/HRP20190977T1/hr unknown
-
2020
- 2020-06-22 US US16/908,244 patent/US11261205B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01156A (es) | ||
| MX2015010125A (es) | Derivados de piridazinona-amidas. | |
| MX2019009132A (es) | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. | |
| MY170713A (en) | Treatment protocol of diabetes type 2 | |
| MX2014013858A (es) | Metodo para tratar un cancer positivo de gd2. | |
| PH12015501588A1 (en) | Compounds and methods for treating bacterial infections | |
| EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
| MX357656B (es) | Alfa-1-microglobulina para usarse en tratamiento de enfermedades relacionadas a mitocondrias. | |
| MX356317B (es) | Tratamiento de síntomas asociados a gastroparesia femenina. | |
| PH12014502065A1 (en) | Vesicular formulations | |
| PH12016501183A1 (en) | Novel compound for treatment of severe hypoglycemia | |
| MX347541B (es) | Analogos de acido sialico. | |
| PH12015502746A1 (en) | Prodrug derivatives of substituted triazolopyridines | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| PH12016501182A1 (en) | Novel compound for treatment of severe hypoglycemia | |
| PH12016501184A1 (en) | Novel compound for treatment of severe hypoglycemia | |
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| MX371037B (es) | Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas. | |
| EA033160B1 (ru) | Соединения для лечения заболеваний, связанных с ишемией-реперфузией | |
| IN2013MU01219A (es) | ||
| NZ750581A (en) | Compositions and methods for treating neurodegenerative diseases and cardiomyopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |